Autres langues AstraZeneca PLC

Actions

AZN

GB0009895292

Produits pharmaceutiques

Marché Fermé - London S.E. 17:35:16 28/08/2026			Varia. 5j.	Varia. 1 janv.
11 970,00 ^GBX	-1,19%		-2,21%	-13,20%

12:53	IDEAYA Biosciences prévoit un essai de phase 3 pour son traitement du cancer du poumon	MT
09:39	Hutchmed annonce que son traitement contre le cancer du poumon améliore la survie sans progression lors d'un essai de phase 3 en Chine	MT

Autres langues

12:53	IDEAYA Biosciences Plans Phase 3 Trial for Lung Cancer Therapy
09:39	Hutchmed Says Lung Cancer Therapy Improves Progression-Free Survival in China Phase 3 Trial
06:15	Hutchmed Reports Positive Results from Phase 3 Trial of Non-small Cell Lung Cancer Drug in China
28/08	Astrazeneca Demonstrates Positive Phase Iii Results for Tezspire in Eosinophilic Esophagitis
28/08	AstraZeneca - Tezspire demonstrates positive Phase III results in eosinophilic esophagitis across both co-primary and all key secondary endpoints
27/08	UK Shares Fall as Global Tensions Mount; AstraZeneca Drops
27/08	European Stocks Close Mostly Lower in Thursday Trading as Investors Await Fed Chair Speech
27/08	Global markets live: Apple, Meta, Nvidia, Salesforce, KKR…
27/08	TEZSPIRE demonstrates positive Phase III results in eosinophilic esophagitis across both co-primary and all key secondary endpoints
27/08	AstraZeneca, Amgen Phase 3 Trial Shows Tezspire Eases Swallowing Difficulties for EoE Patients
27/08	AstraZeneca and Amgen announce positive Tezspire trial results in EoE
27/08	Astrazeneca-Medikament Tezspire erreicht Studienziel bei Ösophagitis
27/08	AstraZeneca's Tezspire Meets Esophagitis Late-Stage Trial Goals
27/08	Amgen and AstraZeneca Demonstrate Positive Phase 3 Results For Tezspire In Eosinophilic Esophagitis
27/08	PPHE Hotel Group swings to half-year profit
27/08	AstraZeneca, Amgen's Tezspire Improves Eosinophilic Esophagitis Symptoms in Late-stage Trial
27/08	AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial
27/08	Syngenta: vende di meno ma guadagna di più nel primo semestre
27/08	AstraZeneca's asthma drug Tezspire meets all goals in late-stage esophagitis trial
27/08	UK Stocks-Factors to watch on August 27
26/08	Daiichi Sankyo and Astrazeneca Initiate Tropion-Urothelial04 Phase 3 Trial of Datroway as Adjuvant Therapy in High-Risk Muscle Invasive Urothelial Cancer
26/08	Daiichi Sankyo, AstraZeneca start phase 3 Datroway trial
26/08	FTSE 100 drifts lower as eyes turn to Nvidia
26/08	A Multibillion-Dollar mRNA Cancer Market Is Taking Shape Targeting Lung Cancer’s Biggest Opportunity
25/08	Melrose soars and stocks climb as oil price cools